ATALANTA
Live / Registered — Registered (as of 29 Apr 2025)
What this means for you
Registered since 29 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98369396
- Registration number
- 7773717
- Mark type
- Stylized text
- Filed
- 22 Jan 2024
- Published for opposition
- 11 Mar 2025
- Registered
- 29 Apr 2025
- Attorney of record
- Susan G. L. Glovsky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurodegenerative diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of human diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurological diseases and disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of pain; Pharmaceutical preparations, namely, RNA therapeutics for the treatment diseases of the central nervous system
Owner
- Atalanta Therapeutics, Inc., Boston, MA, US
- Atalanta Therapeutics, Inc., Boston, MA, US
- Atalanta Therapeutics, Inc., Boston, MA, US
Prosecution history
- 29 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Nov 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 06 Nov 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 16 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Aug 2024 — NON-FINAL ACTION E-MAILED
- 16 Aug 2024 — NON-FINAL ACTION WRITTEN
- 16 Aug 2024 — ASSIGNED TO EXAMINER